USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 5,304 shares of the company’s stock in a transaction that occurred on Monday, November 13th. The shares were sold at an average price of $66.01, for a total value of $350,117.04. Following the completion of the transaction, the director now directly owns 12,011,418 shares of the company’s stock, valued at $792,873,702.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

USANA Health Sciences, Inc. (USNA) opened at $65.85 on Tuesday. USANA Health Sciences, Inc. has a 12 month low of $52.55 and a 12 month high of $71.00. The company has a market capitalization of $1,569.11, a P/E ratio of 17.30 and a beta of 1.07.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, October 24th. The company reported $1.02 EPS for the quarter, beating the consensus estimate of $0.91 by $0.11. USANA Health Sciences had a return on equity of 26.38% and a net margin of 8.79%. The business had revenue of $261.77 million for the quarter, compared to the consensus estimate of $259.52 million. During the same quarter in the prior year, the business earned $2.40 earnings per share. USANA Health Sciences’s revenue for the quarter was up 3.0% on a year-over-year basis. analysts expect that USANA Health Sciences, Inc. will post 3.7 earnings per share for the current fiscal year.

USANA Health Sciences declared that its board has approved a stock repurchase plan on Tuesday, July 25th that permits the company to repurchase $64.60 million in outstanding shares. This repurchase authorization permits the company to buy up to 46% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s management believes its shares are undervalued.

ILLEGAL ACTIVITY NOTICE: “USANA Health Sciences, Inc. (USNA) Director Myron W. Wentz Sells 5,304 Shares of Stock” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at https://www.thecerbatgem.com/2017/11/14/usana-health-sciences-inc-usna-director-myron-w-wentz-sells-5304-shares-of-stock.html.

Several research firms have recently issued reports on USNA. BidaskClub lowered USANA Health Sciences from a “hold” rating to a “sell” rating in a report on Thursday, November 2nd. Pivotal Research reduced their target price on USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating for the company in a report on Wednesday, July 26th.

Institutional investors have recently bought and sold shares of the stock. Northern Trust Corp lifted its position in shares of USANA Health Sciences by 10.5% during the second quarter. Northern Trust Corp now owns 177,630 shares of the company’s stock worth $11,386,000 after acquiring an additional 16,948 shares in the last quarter. American International Group Inc. lifted its position in shares of USANA Health Sciences by 7.1% during the first quarter. American International Group Inc. now owns 6,392 shares of the company’s stock worth $368,000 after acquiring an additional 422 shares in the last quarter. Trust Co. of Vermont lifted its position in shares of USANA Health Sciences by 482.7% during the third quarter. Trust Co. of Vermont now owns 4,708 shares of the company’s stock worth $272,000 after acquiring an additional 3,900 shares in the last quarter. Schroder Investment Management Group lifted its position in shares of USANA Health Sciences by 9.0% during the second quarter. Schroder Investment Management Group now owns 572,186 shares of the company’s stock worth $36,734,000 after acquiring an additional 47,448 shares in the last quarter. Finally, FMR LLC lifted its position in shares of USANA Health Sciences by 3.9% during the second quarter. FMR LLC now owns 1,598,143 shares of the company’s stock worth $102,441,000 after acquiring an additional 60,033 shares in the last quarter. Institutional investors and hedge funds own 44.54% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Stock Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related stocks with our FREE daily email newsletter.